Additionally, XIAP is implicated in resistance to Gemcitabine in pancreatic cancer (Shrikhande et al., 2006), and to Carboplatin in ovarian cancer (Thibault et al., 2018). The gene discussed is XIAP; the disease is pancreatic neoplasm.